ProPhase Labs regains Nasdaq compliance after appointing new independent director

ProPhase Labs, Inc.

Appointed Carolina Abenante as independent director on June 20, 2025.
Abenante will join the Audit Committee effective July 19, 2025, the day after the annual meeting.
Nasdaq confirmed compliance with Listing Rule 5605(c)(2) on June 25, 2025, closing the matter.
Non-compliance stemmed from Eleanor McBrier's resignation in September 2024, causing an audit committee vacancy.

item 3.01

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.